Drp1/p53 interaction mediates p53 mitochondrial localization and dysfunction in septic cardiomyopathy-Reference-Cited by-同舟云学术

Drp1/p53 interaction mediates p53 mitochondrial localization and dysfunction in septic cardiomyopathy

Published:2023-04 Issue: Volume:177 Page:28-37
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

Mukherjee Riddhita,Tetri Laura H.,Li Sin-Jin,Fajardo Giovanni,Ostberg Nicolai P.,Tsegay Kaleb B.,Gera Kanika,Cornell Timothy T.,Bernstein Daniel,Mochly-Rosen Daria,Haileselassie Bereketeab

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference47 articles.

1. Increasing Sepsis rates in the United States: results from National Inpatient Sample, 2005 to 2014;Rubens;J. Intensive Care Med.,2020

2. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study;Rudd;Lancet,2020

3. Profound but reversible myocardial depression in patients with septic shock;Parker;Ann. Intern. Med.,1984

4. Septic cardiomyopathy;Beesley;Crit. Care Med.,2018

5. Left ventricular systolic function evaluated by strain echocardiography and relationship with mortality in patients with severe sepsis or septic shock: a systematic review and meta-analysis;Sanfilippo;Crit. Care,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-31-5p alleviates septic cardiomyopathy by targeting BAP1 to inhibit SLC7A11 deubiquitination and ferroptosis;BMC Cardiovascular Disorders;2024-05-30

2. Exploring the interactions between mitochondria-related genes and the immune microenvironment in sepsis: a bioinformatics study;2024-03-05

3. Inhibition of Pyruvate Dehydrogenase Kinase 4 Protects Cardiomyocytes from lipopolysaccharide-Induced Mitochondrial Damage by Reducing Lactate Accumulation;Inflammation;2024-02-24

4. P53 Regulation upon Lipid Peroxidation and Ferroptosis for Intervention against Atherogenesis;Current Medicinal Chemistry;2024-02-07

5. Dexmedetomidine post-treatment exacerbates metabolic disturbances in septic cardiomyopathy via α2A-adrenoceptor;Biomedicine & Pharmacotherapy;2024-01